NLRP3 and obesity disorder: In addition, HFD‐NLRP3−/− mice displayed a reduction in active caspase‐1 expression as well as in circulating and colonic IL‐1β levels, thus confirming previous evidence describing the involvement of NLRP3 inflammasome in the pathophysiology of obesity and related inflammation.17, 38